首页> 美国卫生研究院文献>Journal of Circulating Biomarkers >Adipose mesenchymal stem cells–derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits
【2h】

Adipose mesenchymal stem cells–derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits

机译:脂肪间充质干细胞来源的外来体减轻了链脲佐菌素诱发的兔的视网膜变性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to evaluate the effect of mesenchymal stem cells (MSCs)–derived exosomes in retina regeneration of experimentally induced diabetes mellitus (DM) in a rabbit model. Exosomes are extracellular vesicles that contain many microRNAs (micRNAs), mRNAs, and proteins from their cells of origin. DM was induced by intravenous (IV) injection of streptozotocin in rabbits. MSCs were isolated from adipose tissue of rabbits. Exosomes were extracted from MSCs by ultracentrifugation. Exosomes were injected by different routes (IV, subconjunctival (SC), and intraocular (IO)). Evaluation of the treatment was carried out by histopathological examination of retinal tissues and assessment of micRNA-222 expression level in retinal tissue by real-time polymerase chain reaction. Histologically, by 12 weeks following SC exosomal treatment, the cellular components of the retina were organized in well-defined layers, while IO exosomal injection showed well-defined retinal layers which were obviously similar to layers of the normal retina. However, the retina appeared after IV exosomal injection as irregular ganglionic layer with increased thickness. MicRNA-222 expression level was significantly reduced in diabetic controls when compared to each of healthy controls and other diabetic groups with IV, SC, and IO routes of injected exosomes (0.06 ± 0.02 vs. 0.51 ± 0.07, 0.28 ± 0.08, 0.48 ± 0.06, and 0.42 ± 0.11, respectively). We detected a significant negative correlation between serum glucose and retinal tissue micRNA-222 expression level (r = −0.749, p = 0.001). We can associate the increased expression of micRNA-222 with regenerative changes of retina following administration of MSCs-derived exosomes. The study demonstrates the potency of rabbit adipose tissue–derived MSCs exosomes in retinal repair. So, exosomes are considered as novel therapeutic vectors in MSCs-based therapy through its role in shuttling of many factors including micRNA-222.
机译:这项研究旨在评估兔模型中间充质干细胞(MSCs)衍生的外泌体在实验诱导的糖尿病(DM)视网膜再生中的作用。外泌体是细胞外囊泡,包含许多来自其起源细胞的microRNA(micRNA),mRNA和蛋白质。通过静脉内(IV)注射兔链脲佐菌素诱导DM。从兔脂肪组织中分离出MSC。通过超速离心从MSC中提取外来体。外泌体通过不同的途径(IV,结膜下(SC)和眼内(IO))注射。通过对视网膜组织进行组织病理学检查并通过实时聚合酶链反应评估视网膜组织中micRNA-222表达水平来进行治疗评估。从组织学上讲,SC外泌体治疗后12周,视网膜的细胞成分被组织在清晰的层中,而IO外泌体注射显示出清晰的视网膜层,这些层明显类似于正常视网膜的层。但是,静脉注射外泌体后,视网膜表现为不规则的神经节层,厚度增加。与健康对照者和其他糖尿病组的注射外泌体的IV,SC和IO途径相比,糖尿病对照中的MicRNA-222表达水平显着降低(0.06±0.02与0.51±0.07、0.28±0.08、0.48±0.06 ,和分别为0.42±0.11)。我们检测到血清葡萄糖与视网膜组织micRNA-222表达水平之间显着负相关(r = -0.749,p = 0.001)。我们可以将增加的micRNA-222表达与MSCs衍生的外泌体给药后视网膜的再生变化联系起来。该研究证明了兔脂肪组织来源的MSCs外泌体在视网膜修复中的功效。因此,由于外泌体在梭化包括micRNA-222在内的许多因素中的作用,因此被认为是基于MSCs疗法中的新型治疗载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号